apl. Prof. Dr. Beatrice Schuler-Thurner

Medizinische Fakultät

The Generation of CAR-transfected NKT Cells for the Immunotherapy of Melanoma (2018) Simon B, Wiesinger M, Marz J, Wistuba-Hamprecht K, Weide B, Schuler-Thurner B, Schuler G, et al. Conference contribution Ex vivo expanded NK Cells from Melanoma Patients receive their Migration in a 3D Model and lyse autologous Melanoma Cells (2018) Rossner S, Czerwinski T, Mark C, Gross S, Karg M, Bosch JJ, Schuler-Thurner B, et al. Conference contribution Hypertonicity-enforced BCL-2 addiction unleashes the cytotoxic potential of death receptors (2018) Sirtl S, Knoll G, Dieu Thuy Trinh , Lang I, Siegmund D, Gross S, Schuler-Thurner B, et al. Journal article The Generation of CAR-Transfected Natural Killer T Cells for the Immunotherapy of Melanoma (2018) Simon B, Wiesinger M, Maerz J, Wistuba-Hamprecht K, Weide B, Schuler-Thurner B, Schuler G, et al. Journal article The simultaneous siRNA-mediated downregulation of PD-1 and CTLA-4 to improve CAR-T cell immunotherapy of melanoma (2018) Simon B, Harrer D, Schuler-Thurner B, Dörrie J, Schaft N, Schuler G, Uslu U Conference contribution Hypertonicity primes malignant melanoma cells for apoptosis (2018) Calance DN, Steixner C, Gross S, Schuler-Thurner B, Knoll G, Ehrenschwender M Journal article Sarcoidosis Under Dendritic Cell Vaccination Immunotherapy in Long-term Responding Patients with Metastatic Melanoma (2017) Uslu U, Erdmann M, Schliep S, Dörrie J, Schaft N, Schuler G, Schuler-Thurner B Journal article Preclinical evaluation of NF-κB-triggered dendritic cells expressing the viral oncogenic driver of Merkel cell carcinoma for therapeutic vaccination (2017) Gerer KF, Erdmann M, Hadrup SR, Lyngaa R, Martin LM, Voll RE, Schuler-Thurner B, et al. Journal article Twelve-year survival and immune correlates in dendritic cell-vaccinated melanoma patients (2017) Gross S, Erdmann M, Haendle I, Voland S, Berger T, Schultz E, Strasser E, et al. Journal article The simultaneous siRNA-mediated downregulation of inhibitory receptors to improve CAR-T cell immunotherapy of melanoma (2017) Simon B, Harrer D, Weide B, Schuler G, Schuler-Thurner B, Dörrie J, Schaft N, Uslu U Conference contribution